Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
Virendra Rambiritch,1 Poobalan Naidoo,2 Goonaseelan Pillai3 1Pharmacology Department, University of KwaZulu-Natal, Durban, 2Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa; 3Scientific Capability Development, Novartis Pharma AG, Basel, Switzerland Aim: To determi...
Enregistré dans:
Auteurs principaux: | Rambiritch V, Naidoo P, Pillai G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef245e3baff44c9da0e8c9768f2374d2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
par: Rambiritch V, et autres
Publié: (2016) -
Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
par: Muhammad Muaaz Munir, et autres
Publié: (2021) -
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
par: Frost C, et autres
Publié: (2018) -
Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
par: Yi Tao, et autres
Publié: (2021) -
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
par: Andreas Port, et autres
Publié: (2021)